CpG methylation is maintained in human cancer cells lacking DNMT1

Nature

Volumn 404, Issue 6781, 2000, Pages 1003-1007

  Rhee, Ina ^a,b   Jalr, Kam Wing ^b   Yen, Ray Whay Chiu ^b   Lengauer, Christoph ^b   Herman, James G ^b   Kinzler, Kenneth W ^a,b   Vogelstein, Bert ^a,b   Baylin, Stephen B ^a,b   Schuebel, Kornel E ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE;

ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; ENZYME ACTIVITY; GENE LOCUS; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

5-METHYLCYTOSINE; BLOTTING, SOUTHERN; CYTOSINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE SILENCING; GENES, P16; HUMANS; TUMOR CELLS, CULTURED;

EID: 0034720284     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35010000     Document Type: Article

References (30)

1. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M. & Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196 (1998).
2. Jones, P. A. & Laird, P. W. Cancer epigenetics comes of age. Nature Genet. 21, 163-167 (1999).
3. Schmutte, C., Yang, A. S., Nguyen, T. T. Beart, R. W. & Jones, P. A. Mechanisms for the involvement of DNA methylation in colon carcinogenesis. Cancer Res. 56, 2375-2381 (1996).
4. Eads, C. A. et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 59, 2302-2306 (1999).
5. Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
6. Hsu, D. W. et al. Two major forms of DNA (cytosine-5) methyltransferase in human somatic tissues. Proc. Natl Acad. Sci. USA 96, 9751-9756 (1999).
7. Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W. & Vogelstein, B. 14-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616-620 (1999).
8. Lengauer, C., Kinzler, K. W. & Vogelstein, B. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl Acad. Sci. USA 94, 2545-2550 (1997).
9. ink4A alleles in neoplasia. Cancer Res. 58, 591-593 (1998).
10. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623-627 (1997).
11. Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B. & Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem. 272, 22322-22329 (1997).
12. Kuo, K. C., McCune, K. A., Gehrke, C. W., Midgett, R. & Ehrlich, M. Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA. Nucleic Acids Res. 8, 4763-4776 (1980).
13. Feinberg, A. P., Gehrke, C. W., Kuo, K. C. & Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159-1161 (1988).
14. Frommer, M. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827-1831 (1992).
15. Okamoto, A. et al. Mutations and altered expression of p16INK4 in human cancer. Proc. Natl Acad. Sci. USA 91, 11045-11049 (1994).
16. Bachman, K. E. et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers. Cancer Res. 59, 798-802 (1999).
17. Santi, D. V., Garrett, C. E. & Barr, P. J. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 33, 9-10 (1983).
18. Santi, D. V., Norment, A. & Garrett, C. E. Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. Proc. Natl Acad. Sci. USA 81, 6993-6997 (1984).
19. Juttermann, R., Li, E. & Jaenisch, R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl Acad. Sci. USA 91, 11797-11801 (1994).
20. Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219-220 (1998).
21. Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
22. Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362-365 (1993).
23. Lei, H. et al. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122, 3195-3205 (1996).
24. Xu, G. L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187-191 (1999).
25. He, T. C. et al. A simplified system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA 95, 2509-2514 (1998).
26. Vertino, P. M., Yen, R. W., Gao, J. & Baylin, S. B. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol. Cell. Biol. 16, 4555-4565 (1996).
27. Jeanpierre, M. Human satellites 2 and 3. Ann. Genet. 37, 163-171 (1994).
28. Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307-2312 (1999).
29. Herman, J. G., Graff, J. R., Myohanen, S., Neikin, B. D. & Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93, 9821-9826 (1996).
30. Cameron, E. E., Bachman, K. E., Myohanen, S., Herman, J. G. & Baylin, S. B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet. 21, 103-107 (1999).